SOLASIA PHARMA K K has a total of 23 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Hong Kong, Australia and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GALERA LABS LLC, IRON THERAPEUTICS HOLDINGS AG and MEDMARK PHARMA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Hong Kong | 5 | |
#2 | Australia | 3 | |
#3 | Republic of Korea | 3 | |
#4 | Singapore | 3 | |
#5 | United States | 3 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | China | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Special acyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Komarnitsky Philip B | 12 |
#2 | Lewis Jonathan | 11 |
#3 | Schwartz Brian Eric | 11 |
#4 | Amedio John C Jr | 4 |
#5 | Renzelmann Brian | 3 |
#6 | Gutsch Paul | 3 |
#7 | Amedio John C Jr Jc | 1 |
#8 | Waligora Frank Walter | 1 |
#9 | Schwartz Brian Eric Be | 1 |
#10 | Lewis Jonathan J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019220961A1 | Crystal form of alkali metal salt and/or inorganic acid addition salt of darinaparsin, and formulation thereof | |
TW201531292A | Compounds and methods for the treatment of cancer |